freeline-logo-red-rgb.jpg
Acquisition of Freeline by Syncona Becomes Effective
February 20, 2024 07:00 ET | FREELINE THERAPEUTICS LIMITED
Acquisition of Freeline by Syncona Becomes Effective
freeline-logo-red-rgb.jpg
Freeline Shareholders Approve Acquisition by Syncona
February 12, 2024 12:00 ET | FREELINE THERAPEUTICS LIMITED
Freeline Shareholders Approve Acquisition by Syncona
freeline-logo-red-rgb.jpg
Syncona to Acquire Freeline Therapeutics
November 22, 2023 07:30 ET | FREELINE THERAPEUTICS LIMITED
Syncona to Acquire Freeline Therapeutics
freeline-logo-red-rgb.jpg
Freeline Presents Positive New Data from Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease at ESGCT 30th Annual Congress
October 25, 2023 02:01 ET | FREELINE THERAPEUTICS LIMITED
Freeline Presents Positive New Data from Phase 1/2 GALILEO-1 Trial of FLT201, Its Novel Gene Therapy Candidate, in Gaucher Disease at ESGCT 30th Annual Con